UBS O'Connor’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-129,666
| Closed | -$1.16M | – | 283 |
|
|
2024
Q4 | $1.16M | Buy |
129,666
+5,464
| +4% | +$48.8K | 0.03% | 208 |
|
|
2024
Q3 | $1.37M | Buy |
124,202
+11,537
| +10% | +$127K | 0.03% | 237 |
|
|
2024
Q2 | $1.03M | Buy |
112,665
+4,545
| +4% | +$41.4K | 0.03% | 289 |
|
|
2024
Q1 | $1.52M | Buy |
108,120
+30,000
| +38% | +$422K | 0.04% | 228 |
|
|
2023
Q4 | $600K | Sell |
78,120
-45,880
| -37% | -$352K | 0.02% | 321 |
|
|
2023
Q3 | $925K | Buy |
124,000
+10,000
| +9% | +$74.6K | 0.02% | 333 |
|
|
2023
Q2 | $950K | Buy |
+114,000
| New | +$950K | 0.02% | 381 |
|